cancer

Researchers from the Broad Stem Cell Research Center created a system to produce human T cells, the white blood cells that fight against disease-causing intruders in the body.

CancerLocator, developed by UCLA researchers, was superior in detecting cancer in blood samples containing low levels of target DNA, which reflect early-stage disease.

Dr. Zev Wainberg, a member of the UCLA Jonsson Comprehensive Cancer Center, sheds light on a handful of common misconceptions about the disease, which kills 50,000 Americans each year.

In this Q&A, UCLA’s Dr. Sara Hurvitz sheds light on the benefits of caps, how they work and if men could use them

UCLA researchers found that a combination therapy going after stem cells and chemotherapy resulted in better outcomes.

Every year as Californians file their state income taxes, they have an opportunity to help University of California researchers and others in the fight against cancer.

New recommendations are needed in part because people with cancer are living longer thanks to improved treatments, giving tumors more time to spread to other parts of the body.

UCLA-led study of DNA patterns in tumor cells suggests that the abundance of aberrant genetic signatures common in more aggressive cancers is not random.

UCLA researchers determined for the first time why some people with advanced melanoma or advanced colon cancer will not respond to pembrolizumab.

Researchers found that combining a vaccine developed at UCLA with two drugs that modulate distinct aspects of the immune system was more effective at allowing T cells to attack glioblastoma than the vaccine alone.

UCLA Jonsson Comprehensive Cancer Center researchers discuss the parallels — and the sometimes unexpected intersections between the two pursuits.

Dr. Edward Garon, UCLA Jonsson Comprehensive Cancer Center member and associate professor of hematology and oncology at the David Geffen School of Medicine, has received a new grant from the National Institutes of Health.

California State Senate will discuss barriers, such as difficult-to-navigate health system, inadequate insurance, and cultural misconceptions, as well as possible solutions Jan. 12.

UCLA-led research found people with advanced head and neck squamous cell carcinoma and a certain genetic mutation have improved survival when given a drug in combination with standard therapies.

UCLA researchers have found that Tianshengyuan-1 increased activity of an enzyme that plays a role in regulating cell division, which is a factor in treating blood cell deficiency and cancer.

Researchers from the schools of dentistry, medicine and engineering developed a digital health platform capable of optimizing efficacy and safety during chemotherapy.

UCLA researchers have discovered a previously unrecognized type of progenitor cell that is found in uncommonly high numbers in inflamed areas of the gland.

UCLA study showed positive results for palbociclib when used in combination with letrozole and without the side effects of traditional chemotherapy.

The development of DZ-2384 by UCLA chemists led to an international research collaboration which found that the molecule appears to help fight several types of cancer.

UCLA researchers note that the next decade shows great promise for things like improving food safety, fighting infections, storing energy and supplying clean energy.

Team up with UCLA Health patients, families and staff members for the fundraiser on Saturday, Oct. 22.

Though the test reduces the number of women undergoing radiation, researchers say doctors and policy makers should further discuss the value of using Oncotype DX DCIS.

The technique involved amplifying a protein signal without using enzymes, which takes the process from two to four hours down to 10 minutes.

The findings are a major step toward confirming an unusual theory of how some cancer cells metastasize, and the study could lead to new strategies for keeping melanoma from spreading.

Researchers at the UCLA Jonsson Comprehensive Cancer Center say findings in new study will help physicians and patients make informed decisions.